Page last updated: 2024-11-12
neopeltolide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
neopeltolide: a macrolide from a lithistid sponge of the family Neopeltidae; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 16115403 |
CHEMBL ID | 223238 |
MeSH ID | M0509142 |
Synonyms (4)
Synonym |
---|
neopeltolide |
CHEMBL223238 |
YRSJLYCTJWNTMF-NRBUTUAXSA-N |
[(1r,5r,7r,9s,11r,13r)-7-methoxy-9-methyl-3-oxo-5-propyl-4,15-dioxabicyclo[9.3.1]pentadecan-13-yl] (z)-5-[2-[(z)-3-(methoxycarbonylamino)prop-1-enyl]-1,3-oxazol-4-yl]pent-2-enoate |
Research Excerpts
Overview
Neopeltolide (1) is a potent inhibitor of the in vitro proliferation of the A-549 human lung adenocarcinoma, the NCI-ADR-RES human ovarian sarcoma, and the P388 murine leukemia cell lines.
Excerpt | Reference | Relevance |
---|---|---|
"Neopeltolide (1) is a potent inhibitor of the in vitro proliferation of the A-549 human lung adenocarcinoma, the NCI-ADR-RES human ovarian sarcoma, and the P388 murine leukemia cell lines, with IC50's of 1.2, 5.1, and 0.56 nM, respectively." | ( Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. Botelho, JC; Guzmán, E; Harmody, D; Linley, P; McCarthy, PJ; Pitts, TP; Pomponi, SA; Reed, JK; Wright, AE, 2007) | 2.5 |
Effects
Excerpt | Reference | Relevance |
---|---|---|
"Neopeltolide has been proven to be a new type of inhibitor of the cytochrome bc" | ( Natural Product Neopeltolide as a Cytochrome bc Song, YJ; Wang, YX; Wu, QY; Yang, GF; Yang, JF; Zhang, R; Zhu, XL, 2019) | 1.58 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (31)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID280375 | Cell cycle arrest in A549 cells by accumulation at G2/M phase at 100 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500483 | Antifungal activity against Saccharomyces cerevisiae W303-1A in glycerol agar media at 1 ug after 24 hrs by disk diffusion method | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280370 | Cytotoxicity against mouse NCI-P388 cells by MTT assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500487 | Inhibition of bc1 complex in human A549 cells assessed as reduction in ATP production in presence of 10 mM of 2-DG | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280378 | Cell cycle arrest in A549 cells by accumulation at G2/M phase at 10 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280369 | Cytotoxicity against human NCI-ADR-RES cells by MTT assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500493 | Inhibition of Saccharomyces cerevisiae Cytochrome b-c1 complex | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280367 | Antifungal activity against Candida albicans ATCC 44506 by broth dilution assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280373 | Cell cycle arrest in A549 cells by accumulation at G1 phase at 100 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280377 | Cell cycle arrest in A549 cells by accumulation at S phase at 10 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500495 | Inhibition of bovine Cytochrome b-c1 complex | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280371 | Cytotoxicity against p53 mutated PANC1 cells ATCC CRL1469 by MTT assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280384 | Cell cycle arrest in A549 cells by accumulation at G2/M phase at 0.1 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280368 | Cytotoxicity against human A549 cells ATCC CCL-185 by MTT assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280381 | Cell cycle arrest in A549 cells by accumulation at G2/M phase at 1 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500498 | Effect on cytochrome c oxidase activity of respiratory chain in Saccharomyces cerevisiae W303-1A mitochondria at 100 mM | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID500484 | Antifungal activity against Saccharomyces cerevisiae W303-1A in glucose agar media at 1 ug after 24 hrs by disk diffusion method | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID500470 | Inhibition of cell proliferation in human HCT116 cells in after 48 hrs | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280366 | Antifungal activity against Candida albicans ATCC 44506 at 25 ug/disk by agar diffusion assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500496 | Effect on NADH dehydrogenase in respiratory chain of Saccharomyces cerevisiae W303-1A mitochondria at 100 mM | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280374 | Cell cycle arrest in A549 cells by accumulation at S phase at 100 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500468 | Inhibition of cell proliferation in human A549 cells in after 48 hrs | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280380 | Cell cycle arrest in A549 cells by accumulation at S phase at 1 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280383 | Cell cycle arrest in A549 cells by accumulation at S phase at 0.1 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280382 | Cell cycle arrest in A549 cells by accumulation at G1 phase at 0.1 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500715 | Effect on succinate:ubiquinone oxidoreductase activity of respiratory chain in Saccharomyces cerevisiae W303-1A mitochondria at 100 mM | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID500488 | Inhibition of bc1 complex in human A549 cells assessed as reduction in ATP production | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280379 | Cell cycle arrest in A549 cells by accumulation at G1 phase at 1 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID500469 | Inhibition of cell proliferation in human PC3 cells in after 48 hrs | 2008 | Nature chemical biology, Jul, Volume: 4, Issue:7 | Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. |
AID280376 | Cell cycle arrest in A549 cells by accumulation at G1 phase at 10 nM | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
AID280372 | Cytotoxicity against p53 mutated NCI-DLD1 cells by MTT assay | 2007 | Journal of natural products, Mar, Volume: 70, Issue:3 | Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (35)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (42.86) | 29.6817 |
2010's | 18 (51.43) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.22
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.22) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 3 (8.57%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 32 (91.43%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |